| Literature DB >> 22822500 |
David M Goldenberg, Robert M Sharkey.
Abstract
"Progress in the use of RAIT for cancer therapy has been slow but steady, involving the reengineerin1g of antibodies (reducing murine component, altering size and clearance properties), and pretargeting methods for improvving tumor:blood and tumor:organ ratios are continuing to evolve".Entities:
Mesh：
Substances：
Year: 2011 PMID： 22822500 DOI： 10.4155/tde.11.44
Source DB: PubMed Journal: Ther Deliv ISSN： 2041-5990